Skip to content

Validation of a Seizure Monitoring System

Validation of a Seizure Monitoring System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03465189
Enrollment
10
Registered
2018-03-14
Start date
2018-09-10
Completion date
2020-03-19
Last updated
2020-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The investigators aim to determine the feasibility of using the Medtronic LINQ device for epilepsy diagnosis, monitoring and management. The feasibility will be determined by comparing EEG signals from the LINQ system to the gold standard clinical recordings. If seizures can be identified using the LINQ device with the same level of accuracy as adjacent scalp EEG recording electrodes, then the LINQ will be deemed feasible.

Interventions

DEVICEMedtronic LINQ Device

Using two LINQ devices that are fixed to scalp to record EEG (in addition to the standard scalp EEG).

Sponsors

University of Melbourne
CollaboratorOTHER
Seer Medical
CollaboratorUNKNOWN
St Vincent's Hospital Melbourne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with epilepsy

Exclusion criteria

* Women that are pregnant * Patients that are highly dependant on medical care * Patients that cannot give informed consent for themselves

Design outcomes

Primary

MeasureTime frameDescription
Verify feasibility of using the LINQ device for epilepsy diagnosis, monitoring and managementone weekCompare EEG from traditional scalp EEG to the LINQ recordings to determine if seizure activity can be accurately identified

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026